PROVIDER PROFILE · NPI 1902899396

Rominder KaurMD

Internal MedicineHighland Village, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

408

Unique beneficiaries

—

Total services

851

Distinct HCPCS

Medicare payment

$59K

Peer benchmark

Total Medicare services vs. 6,183 Internal Medicine providers in TX — above median (cohort median 673).

PRESCRIBING · PART D · 2024

Total Rx claims

4,163

Beneficiaries

—

Total drug cost

$123K

Distinct drugs

Brand share

18.2%

Top prescribed drugs

Levothyroxine Sodium341 claims

Amlodipine Besylate309 claims

Atorvastatin Calcium217 claims

Rosuvastatin Calcium215 claims

Hydrochlorothiazide149 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$756

Payment records

By payment type

Food and Beverage$756

REFERRAL NETWORK

Where Rominder Kaur's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX	175	1,296
COLUMBIA MEDICAL CENTER OF LEWISVILLE SUBSIDIARY LP	33	120
Cherry Chandi Internal Medicine · Highland Village, TX	16	80
Russell Snook Ophthalmology · Lewisville, TX	13	24
Laboratory Corporation Of America Clinical Laboratory · Dallas, TX	12	64
Carolyn Lyde Dermatology · Lewisville, TX	12	32

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history